Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
UBS
Cerilliant
Express Scripts
US Army
Fish and Richardson
Healthtrust
Dow
Fuji

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,815,942

« Back to Dashboard

Which drugs does patent 7,815,942 protect, and when does it expire?

Patent 7,815,942 protects AZILECT and is included in one NDA.

This patent has twenty-six patent family members in eighteen countries.
Summary for Patent: 7,815,942
Title:Rasagiline formulations of improved content uniformity
Abstract:Disclosed are pharmaceutical preparations of R(+)-N-propargyl-1-aminoindan salts having enhanced content uniformity, processes for preparation of the compositions, and their uses.
Inventor(s): Peskin; Tirtza Berger (Raanana, IL)
Assignee: Teva Pharmaceutical Industries, Ltd. (Petach Tikva, IL)
Application Number:11/359,324
Patent Claim Types:
see list of patent claims
Compound; Composition; Dosage form; Use; Process;

Drugs Protected by US Patent 7,815,942

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Teva AZILECT rasagiline mesylate TABLET;ORAL 021641-001 May 16, 2006 AB RX Yes No ➤ Sign Up ➤ Sign Up Y Y TREATMENT OF PARKINSON'S DISEASE ➤ Sign Up
Teva AZILECT rasagiline mesylate TABLET;ORAL 021641-002 May 16, 2006 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y TREATMENT OF PARKINSON'S DISEASE ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cerilliant
US Army
Boehringer Ingelheim
Deloitte
Queensland Health
Argus Health
Teva
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.